These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36363460)

  • 1. Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.
    Mir SA; Ara R; Amin F; Malik A; Hamid L; Ali T; Bader GN; Wani SUD; Almuqbil M; Alshehri S; Alshehri AM; Shakeel F
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.
    Kriplani A; Srivastava A; Kulshrestha V; Kachhawa G; Agarwal N; Bhatla N; Hari S
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1744-1752. PubMed ID: 27647770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Ormeloxifene and Medroxyprogesterone Acetate in Abnormal Uterine Bleeding.
    Godha Z; Mohsin Z; Hakim S; Wasim S
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):395-9. PubMed ID: 27651636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclical progestogens for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial.
    Kuppermann M; Varner RE; Summitt RL; Learman LA; Ireland C; Vittinghoff E; Stewart AL; Lin F; Richter HE; Showstack J; Hulley SB; Washington AE;
    JAMA; 2004 Mar; 291(12):1447-55. PubMed ID: 15039411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.
    Munro MG; Mainor N; Basu R; Brisinger M; Barreda L
    Obstet Gynecol; 2006 Oct; 108(4):924-9. PubMed ID: 17012455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.
    Bender RA
    Med Sci Monit; 2022 Jun; 28():e936727. PubMed ID: 35746846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.
    Ravibabu K; Palla J; Chintada GS
    J Clin Diagn Res; 2013 Nov; 7(11):2534-6. PubMed ID: 24392393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study.
    Ammerman SR; Nelson AL
    Am J Obstet Gynecol; 2013 Jun; 208(6):499.e1-5. PubMed ID: 23395929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicine or Surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding.
    Varner RE; Ireland CC; Summitt RL; Richter HE; Learman LA; Vittinghoff E; Kuppermann M; Washington E; Hulley SB;
    Control Clin Trials; 2004 Feb; 25(1):104-18. PubMed ID: 14980755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid.
    Goshtasebi A; Moukhah S; Gandevani SB
    Arch Gynecol Obstet; 2013 Nov; 288(5):1055-60. PubMed ID: 23595582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate treatment of abnormal uterine bleeding: factors predicting satisfaction.
    Richter HE; Learman LA; Lin F; Varner RE; Hendrix SL; Summitt RL; Washington AE
    Am J Obstet Gynecol; 2003 Jul; 189(1):37-42. PubMed ID: 12861135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding.
    Yu Y; Zhou Z; Wang L; Liu J
    Comput Math Methods Med; 2022; 2022():5648918. PubMed ID: 36238482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.